PB1 domain-mediated heterodimerization in NADPH oxidase and signaling complexes of atypical protein kinase C with Par6 and p62

Molecular Cell

Volumn 12, Issue 1, 2003, Pages 39-50

  Wilson, Michael I ^a   Gill, David J ^a   Perisic, Olga ^a   Quinn, Mark T ^b   Williams, Roger L ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDOREDUCTASE; PROTEIN; PROTEIN KINASE C; PROTEIN P40; PROTEIN P62; PROTEIN P67; PROTEIN PB1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL POLARITY; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIMERIZATION; ELECTRICITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN MOTIF; PROTEIN STRUCTURE;

ANIMALIA;

EID: 0041625934     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00246-6     Document Type: Article

References (60)

1. Abrahams J.P., Leslie A.G.W. Methods used in the structure determination of bovine mitochondrial F1 ATPase. Acta Crystallogr. D. 52:1996;30-42.
2. Avila A., Silverman N., Diaz-Meco M.T., Moscat J. The Drosophila atypical protein kinase C-ref(2)p complex constitutes a conserved module for signaling in the toll pathway. Mol. Cell. Biol. 22:2002;8787-8795.
3. Babior B.M. NADPH oxidase. an update Blood. 93:1999;1464-1476.
4. Banfi B., Clark R.A., Steger K., Krause K.H. Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J. Biol. Chem. 278:2003;3510-3513.
5. Bateman A., Birney E., Durbin R., Eddy S.R., Howe K.L., Sonnhammer E.L.L. The Pfam protein families data base. Nucleic Acids Res. 28:2000;263-266.
6. phox bound to phosphatidylinositol 3-phosphate. Mol. Cell. 8:2001;829-839.
7. Brown G.E., Stewart M.Q., Liu H., Hal V.-L., Yaffe M.B. A novel assay system implicates PtdIns(3,4)P2, PtdIns(3)P, and PKCδ in intracellular production of reactive oxygen species by the NADPH oxidase. Mol. Cell. 11:2003;35-47.
8. CCP4 The CCP4 (Collaborative Computing Project 4) suite. programs for protein crystallography Acta Crystallogr D. 50:1994;760-763.
9. C receptors, PKC-ζ, and Kvβ2. J. Biol. Chem. 278:2003;6128-6135.
10. Cross A.R., Noack D., Rae J., Curnutte J.T., Heyworth P.G. Hematologically important mutations. the autosomal recessive forms of chronic granulomatous disease (first update) Blood Cells Mol. Dis. 26:2000;561-565.
11. de La Fortelle E., Bricogne G. Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods. Methods Enzymol. 276:1997;472-494.
12. phox. Nat. Cell Biol. 3:2001;679-682.
13. Etienne-Manneville S., Hall A. Cdc42 regulates GSK-3β and adenomatous polyposis coli to control cell polarity. Nature. 421:2003;753-756. a.
14. Etienne-Manneville S., Hall A. Cell polarity. Par6, aPKC and cytoskeletal crosstalk Curr. Opin. Cell Biol. 15:2003;67-72. b.
15. Gao L., Joberty G., Macara I.G. Assembly of epithelial tight junctions is negatively regulated by Par6. Curr. Biol. 12:2002;221-225.
16. phox homolog. J. Leukoc. Biol. 71:2002;319-328.
17. phox support superoxide production by NAD(P)H oxidase 1 in colon epithelial cells. J. Biol. Chem. 278:2003;20006-20012.
18. Gong J., Xu J., Bezanilla M., van Huizen R., Derin R., Li M. Differential stimulation of PKC phosphorylation of potassium channels by ZIP1 and ZIP2. Science. 285:1999;1565-1569.
19. phox. Structure at 1.8 Å resolution and biochemical characterizations of the A128V mutant implicated in chronic granulomatous disease. J. Biol. Chem. 276:2001;21627-21631. a.
20. phox. Biochemistry. 40:2001;3127-3133. b.
21. Heyworth P.G., Curnutte J.T., Rae J., Noack D., Roos D., van Koppen E., Cross A.R. Hematologically important mutations. X-linked chronic granulomatous disease (second update) Blood Cells Mol. Dis. 27:2001;16-26.
22. Hiroaki H., Ago T., Ito T., Sumimoto H., Kohda D. Solution structure of the PX domain, a target of the SH3 domain. Nat. Struct. Biol. 8:2001;526-530.
23. Huang L., Hofer F., Martin G.S., Kim S.-H. Structural basis for the interaction of Ras with RalGDS. Nat. Struct. Biol. 5:1998;422-426.
24. Huynh J.R., Petronczki M., Knoblich J.A., St Johnston D. Bazooka and PAR-6 are required with PAR-1 for the maintenance of oocyte fate in Drosophila. Curr. Biol. 11:2001;901-906.
25. Ito T., Matsui Y., Ago T., Ota K., Sumimoto H. Novel modular domain PB1 recognizes PC motif to mediate functional protein-protein interactions. EMBO J. 20:2001;3938-3946.
26. Jones T.A., Zou J.-Y., Cowan S.W., Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A. 47:1991;110-119.
27. phox, Grb2 and Pex13p. EMBO J. 21:2002;4268-4276.
28. phox to phosphatidylinositol 3,4-bisphosphate and phosphatidic acid is masked by an intramolecular interaction. EMBO J. 21:2002;5057-5068.
29. phox as a positive regulator of the superoxide-producing phagocyte oxidase. EMBO J. 21:2002;6312-6320.
30. phox in complex with Rac•GTP. Mol. Cell. 6:2000;899-907.
31. phox J. Biol. Chem. 277:2002;10121-10128.
32. Lo Conte L., Brenner S.E., Hubbard T.J., Chothia C., Murzin A.G. SCOP database in 2002. refinements accommodate structural genomics Nucleic Acids Res. 30:2002;264-267.
33. Moscat J., Diaz-Meco M.T. The atypical protein kinase Cs. Functional specificity mediated by specific protein adapters. EMBO Rep. 1:2000;399-403.
34. Moscat J., Diaz-Meco M.T., Rennert P. NF-κB activation by protein kinase C isoforms and B-cell function. EMBO Rep. 4:2003;31-36.
35. phox, SH3 domain-containing cytosolic factors of the phagocyte NADPH oxidase Eur. J. Biochem. 251:1998;583-589.
36. Nassar M., Horn G., Herrmann C., Scherer A., McCormick F., Wittinghofer A. The 2.2 Å crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue. Nature. 375:1995;554-560.
37. phox component of phagocyte NADPH oxidase. Hum. Genet. 105:1999;460-467.
38. Ohno S. Intercellular junctions and cellular polarity. the PAR-aPKC complex, a conserved core cassette playing fundamental roles in cell polarity Curr. Opin. Cell Biol. 13:2001;641-648.
39. Otomo T., Sakahira H., Uegaki K., Nagata S., Yamazaki T. Structure of the heterodimeric complex between CAD domains of CAD and ICAD. Nat. Struct. Biol. 7:2000;658-662.
40. Pacold M.E., Suire S., Perisic O., Lara-Gonzalez S., Davis C.T., Walker E.H., Hawkins P.T., Stephens L., Eccleston J.F., Williams R.L. Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. Cell. 103:2000;931-943.
41. phox. Blood. 94:1999;2505-2514.
42. phox mutants with unmasked SH3 domains. full reconstitution of oxidase activity in a semi-recombinant cell-free system lacking arachidonic acid Biochem. J. 373:2003;221-229.
43. Perrakis A., Morris R., Lamzin V.S. Automated protein model building combined with iterative structure refinement. Nat. Struct. Biol. 6:1999;458-463.
44. Petronczki M., Knoblich J.A. DmPAR-6 directs epithelial polarity and asymmetric cell division of neuroblasts in Drosophila. Nat. Cell Biol. 3:2001;43-49.
45. Plant P.J., Fawcett J.P., Lin D.C., Holdorf A.D., Binns K., Kulkarni S., Pawson T. A polarity complex of mPar-6 and atypical PKC binds, phosphorylates and regulates mammalian Lgl. Nat. Cell Biol. 5:2003;301-308.
46. Ponting C.P. Novel domains in NADPH oxidase subunits, sorting nexins, and PtdIns 3-kinases. binding partners of SH3 domains? Protein Sci. 5:1996;2353-2357.
47. Ponting C.P., Ito T., Moscat J., Diaz-Meco M.T., Inagaki F., Sumimoto H. Opr, pc and aid. all in the PB1 family Trends Biochem. Sci. 27:2002;10.
48. Puls A., Schmidt S., Grawe F., Stabel S. Interaction of protein kinase C zeta with ZIP, a novel protein kinase C-binding protein. Proc. Natl. Acad. Sci. USA. 94:1997;6191-6196.
49. Roccato E., Pagliardini S., Cleris L., Canevari S., Formelli F., Pierotti M.A., Greco A. Role of TFG sequences outside the coiled-coil domain in TRK-T3 oncogenic activation. Oncogene. 22:2003;807-818.
50. Sanz L., Sanchez P., Lallena M.J., Diaz-Meco M.T., Moscat J. The interaction of p62 with RIP links the atypical PKCs to NF-κB activation. EMBO J. 18:1999;3044-3053.
51. Schultz J., Copley R.R., Doerks T., Ponting C.P., Bork P. Smart. a web-based tool for the study of genetically mobile domains Nucleic Acids Res. 28:2000;231-234.
52. Shin J. P62 and the sequestosome, a novel mechanism for protein metabolism. Arch. Pharm. Res. 21:1998;629-633.
53. Stumptner C., Fuchsbichler A., Heid H., Zatloukal K., Denk H. Mallory body - a disease-associated type of sequestosome. Hepatology. 35:2002;1053-1062.
54. Sun W., Kesavan K., Schaefer B.C., Garrington T.P., Ware M., Johnson N.L., Gelfand E.W., Johnson G.L. MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway. J. Biol. Chem. 276:2001;5093-5100.
55. Terasawa H., Noda Y., Ito T., Hatanaka H., Ichikawa S., Ogura K., Sumimoto H., Inagaki F. Structure and ligand recognition of the PB1 domain. a novel protein module binding to the PC motif EMBO J. 20:2001;3947-3956.
56. Terwilliger T.C., Berendzen J. Automated structure solution for MIR and MAD. Acta Crystallogr. D. 55:1999;849-861.
57. phox. Biochem. Biophys. Res. Commun. 199:1994;1378-1387.
58. phox, a third cytosolic component of the activation complex of the NADPH oxidase to contain src homology 3 domains. Biochem. J. 296:1993;557-561.
59. Yamanaka T., Horikoshi Y., Suzuki A., Sugiyama Y., Kitamura K., Maniwa R., Nagai Y., Yamashita A., Hirose T., Ishikawa H.et al. PAR-6 regulates aPKC activity in a novel way and mediates cell-cell contact-induced formation of the epithelial junctional complex. Genes Cells. 6:2001;721-731.
60. Zatloukal K., Stumptner C., Fuchsbichler A., Heid H., Schnoelzer M., Kenner L., Kleinert R., Prinz M., Aguzzi A., Denk H. p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am. J. Pathol. 160:2002;255-263.